Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Catharina Ziekenhuis Eindhoven
Assistance Publique - Hôpitaux de Paris
Alliance for Clinical Trials in Oncology
Zhejiang University
Clinique Paris-Bercy
UNICANCER
Northwestern University
OHSU Knight Cancer Institute
Sorlandet Hospital HF
University of Minnesota
Memorial University of Newfoundland
Alaska Native Tribal Health Consortium
VA Office of Research and Development
Emory University
Dartmouth-Hitchcock Medical Center
Chinese University of Hong Kong
Uppsala University Hospital
University of California, San Diego